Navigation Links
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:10/3/2007

SAN DIEGO, Oct. 3 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to provide a corporate overview of its clinical development and discovery programs at two upcoming investor conferences:

-- Natixis Bleichroeder Hidden Gems Conference

Presentation: Monday, October 8, 2007 at 8:00 a.m. Eastern Time (5:00

a.m. Pacific Time) at the Carlton Hotel on Madison Avenue in New York

City

Presenting: Robert E. Hoffman, Arena's Vice President, Finance and

Chief Financial Officer

-- BIO InvestorForum 2007

Presentation: Wednesday, October 10, 2007 at 2:15 p.m. Pacific Time

(5:15 p.m. Eastern Time) at the Palace Hotel in San Francisco

Presenting: Louis J. Scotti, Arena's Vice President, Marketing and

Business Development

A live audio webcast of each presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. Replays of the presentations will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeli
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...
(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...
(Date:5/20/2013)... -- Dr. Gerald Zon , noted scientist ... a new blog in conjunction with TriLink BioTechnologies. The ... on what,s trending in the field of nucleic acids. ... of research presented at conferences and meetings, reviews of ... (PhD Princeton University 1971) developed automated synthesis of DNA ...
(Date:5/20/2013)... With bed bugs' presence come problems in various terms. ... to be eliminated, one must make sure that the bed ... so to help bed bug sufferers get that done, it ... bugs without using harmful pesticides. In it, the company ... Bug Bully. , According to My Cleaning Products, contrary to ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2
... ExonHit Therapeutics, a,drug and diagnostic discovery company, ... disease test. The company expects to have,this test ... in its GLP (Good,Laboratory Practices) compliant laboratories to ... initial ExonHit test aims to identify patients suffering ...
... WALTHAM, Mass., Nov. 8 Inverness Medical,Innovations, Inc. (Amex: ... to sell,subject to market and other conditions, 7,000,000 shares ... statement in an,underwritten public offering. Certain selling stockholders of ... shares of common stock in the,offering. The Company expects ...
... Navy, The Citadel Are Among The Organizations Advocating Use ... Cleansers With CHG for Ongoing Prevention and Protection, ... Staphylococcus aureus) deadlier than AIDS, and the media continue,to ... most extreme cases,student deaths due to this drug-resistant staph ...
Cached Biology Technology:ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 2ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 3ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 4Inverness Medical Innovations Announces Proposed Public Offering of Common Stock 2Inverness Medical Innovations Announces Proposed Public Offering of Common Stock 3Soap and Water May not be Enough to Fight MRSA Superbug 2Soap and Water May not be Enough to Fight MRSA Superbug 3
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... 18, 2013) The AGA Research Foundation announced a ... relationship between the gut microbiota, one of today,s most ... , The AGA Research Awards Panel selected Andrew ... General Hospital and Harvard Medical School, Boston, as the ... Chan will receive $25,000 of funding, commencing in July ...
(Date:5/17/2013)... the science and technology of the region and ... inaugural Atlanta Science Festival, March 22-29, 2014. With ... K-12 schools and universities, the festival will host ... adults at venues across the city. Learn more ... Atlanta Science Festival is a collaboration of scientific, ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2
... ever found in Canada is revealing how plants struggled to ... -- buried by a landslide and exquisitely preserved 2 to ... today,s Arctic will respond to global warming. They also ... America as Arctic ice continues to melt. As the wood ...
... of Oceanography at UC San Diego have provided the ... light produced by a little-known sea snail. Dimitri ... now at the Australian Museum in Sydney) studied a ... found in tight clusters or groups at rocky shorelines. ...
... They say it,s the little things that count, and that ... which are small enough to allow ions or molecules of ... objects. Artificial fluidic nanochannels that mimic the capabilities of transmembrane ... However, it has been difficult to make individual artificial channels ...
Cached Biology News:Ancient forest emerges mummified from the Arctic 2Ancient forest emerges mummified from the Arctic 3Scripps scientists see the light in bizarre bioluminescent snail 2Tiny channels carry big information 2Tiny channels carry big information 3
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...
... adapter allows the Thermo-Fast® ... AB-1000) PCR plates to ... ABI PRISM® 3700 capillary ... for information on the ...
The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures ...
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
Biology Products: